A joint venture between Bondholder Tioga and the University of Nottingham is one of only three UK companies to benefit from a new agreement between the Department for International Trade in the UK and the Texas Medical Centre.
SurePulse Medical Ltd is a medical devices company committed to developing user centred vital sign monitoring solutions which have a real clinical benefit. They are committed to providing reliable vital sign monitoring solutions where they are needed most, with their first product targeted for neonatal care.
Just three months after being selected as the winner of the Medilink East Midlands Start-up award the team will be able to take advantage of the opportunities which will open up to them. This follows a landmark agreement called BioBridge which will provide a gateway for the advancement of life sciences in the areas of innovation and research.
James Carpenter, CEO of SurePulse, said: “This collaboration between the UK and Texas Medical Centre has been instrumental in helping SurePulse to accelerate its USA regulatory and marketing strategy. We look forward to building on this foundation to bring SurePulse vital sign monitoring solutions into the US clinic faster and to advance care for thousands of babies who need help at birth.”
Speaking at the launch event Baroness Rona Fairhead, Minister of State for the Department of International Trade, said: "The UK is a world leader in healthcare innovation, and this partnership is clear evidence of the opportunities that exist for companies in exciting markets such as the USA."